Status | Study |
Recruiting |
Study Name: Controls for Respiratory Diseases Condition: Chronic Obstructive Pulmonary Disease Asthma Idiopathic Pu Date: 2017-04-14 Interventions: Other: no intervation no intervention |
Recruiting |
Study Name: Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease Condition: Mycobacterium Infections, Nontuberculous Mycobacteria, Atypical Date: 2017-01-03 Interventions: Drug: LAI plus multi-drug regimen Liposomal Amikacin for Inhalation (LAI) is the experimental treatment |
Not yet recruiting |
Study Name: Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Condition: Mycobacterium Avium Complex Date: 2016-11-10 Interventions: Drug: Clofazimine All particip |
Not yet recruiting |
Study Name: Genome-Wide Association Study in Patients With Nontuberculous Mycobacterial Lung Disease Condition: Mycobacterium Infections, Nontuberculous Date: 2016-07-03 |
Completed |
Study Name: Program Cell Death Receptor 1 in Mycobacterium Avium Complex Lung Disease Condition: Mycobacterium Avium Date: 2016-05-18 Interventions: Other: Blood examination blood sampling |
Recruiting |
Study Name: A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections Condition: Mycobacterium Infections, Nontuberculous Date: 2015-01-28 |
Active, not recruiting |
Study Name: Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone Condition: Mycobacterium Infections, Nontuberculous Date: 2015-01-09 Interventions: Drug: Liposomal Amikacin for Inhalation |
Completed |
Study Name: Diagnostic Accuracy of Nontuberculous Mycobacterial Lung Disease Based on Chest CT Condition: Mycobacterium Infections, Nontuberculous Date: 2014-12-27 |
Withdrawn |
Study Name: Improving Tolerance of Treatment of Pulmonary MAC Infections Condition: Mycobacterium Avium Complex Adverse Effects Date: 2012-10-22 Interventions: Drug: Zofran (8mg) Subject wil |
Completed |
Study Name: Treatment Outcomes in Patient With Nontuberculous Mycobacterial Disease Condition: Nontuberculous Mycobacterial Disease, Atypical Mycobacterium Infection Date: 2012-08-31 |